Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience, health risks, and extreme weather.

Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.

Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans social brains.

In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.

Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.

From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.

Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts degree in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.

Pages

Shots - Health Blog
1:49 pm
Mon September 24, 2012

Experimental Drug Is First To Help Kids With Premature-Aging Disease

Sam Berns, 15, who has the very rare premature-aging disease progeria, plays the drums in his high school's marching band.
Courtesy of the Progeria Research Foundation

Originally published on Tue September 25, 2012 3:11 pm

Researchers have found the first drug to treat progeria, an extremely rare genetic disease that causes children to age so rapidly that many die in their teens.

The drug, called lonafarnib, is not a cure. But in a study published Monday of 28 children, it reversed changes in blood vessels that usually lead to heart attacks and strokes.

Read more
Shots - Health Blog
1:33 am
Thu September 20, 2012

New Experimental Drug Offers Autism Hope

Andy Tranfaglia, 23, who has Fragile X syndrome, rides a horse with his mother, Katie Clapp.
Katie Clapp

Originally published on Thu September 20, 2012 8:10 am

An experimental drug that helps people who have Fragile X syndrome is raising hopes of a treatment for autism.

The drug, called arbaclofen, made people with Fragile X less likely to avoid social interactions, according to a study in Science Translational Medicine. Researchers suspect it might do the same for people with autism.

Read more
Shots - Health Blog
2:49 pm
Tue September 18, 2012

Link Between BPA And Childhood Obesity Is Unclear

Canned food is a source of BPA exposure, but researchers aren't sure whether it causes childhood obesity. Above, the soup isle at a grocery store in Washington, D.C.
Maggie Starbard NPR

Originally published on Tue September 18, 2012 6:23 pm

BPA could be making kids fat. Or not.

That's the unsatisfying takeaway from the latest study on bisphenol A — the plastic additive that environmental groups have blamed for everything from ADHD to prostate disease.

Unfortunately, the science behind those allegations isn't so clear. And the new study on obesity in children and teens is no exception.

Read more

Pages